S
CRMD icon

SignatureFD’s CorMedix CRMD Stock Holding History

SignatureFD’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.01K Hold
383
– – ﹤0.01% 3032
2026
Q1 		$2.6K Buy
+383
New +$2.83K ﹤0.01% 2990
2025
Q4 		– Sell
-37
Closed -$430 – 3438
2025
Q3 		$430 Hold
37
– – ﹤0.01% 3210
2025
Q2 		$456 Buy
+37
New +$408 ﹤0.01% 3120
2024
Q4 		– Sell
-1,000
Closed -$8.08K – 3326
2024
Q3 		$8.08K Buy
+1,000
New +$5.41K ﹤0.01% 2419

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SignatureFD's CRMD Position: Q2 2026 in Review

SignatureFD held its CorMedix (CRMD) position steady in Q2 2026 at 383 shares worth $3.01K. The position accounts for ﹤0.01% of the portfolio, ranked #3032.

SignatureFD first reported a position in CRMD in Q3 2024 and has held it in 5 quarters since. The position peaked at $8.08K in Q3 2024. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • SignatureFD held 383 shares of CorMedix worth $3.01K as of Q2 2026.
  • SignatureFD left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3032 holding.
  • SignatureFD first reported a position in CorMedix in Q3 2024 and has held it in 5 quarters since.
  • SignatureFD's CorMedix position peaked at $8.08K in Q3 2024.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.